Danaher Valuation

Q: What is the Fair Price of DHER34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

DHER34 (R$49.4) is trading above our estimate of [[fair value]] (R$33.76)

Is DHER34 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DHER34 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DHER34 (R$49.4) is trading above our estimate of fair value (R$33.76)

Significantly Below Fair Value: DHER34 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DHER34?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for DHER34. This is calculated by dividing DHER34's market cap by their current preferred multiple.
What is DHER34's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	n/a

DHER34 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	8.1x
Enterprise Value/EBITDA	25.5x
PEG Ratio	3x

Price to Earnings Ratio vs Peers

How does DHER34's PE Ratio compare to its peers?

The above table shows the PE ratio for DHER34 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	39.7x
TMO Thermo Fisher Scientific	33.7x	11.8%	US$209.2b
A Agilent Technologies	27.2x	4.1%	US$38.5b
IQV IQVIA Holdings	27.6x	13.8%	US$39.4b
LONN Lonza Group	70.4x	23.9%	CHF 40.4b
DHER34 Danaher	44x	14.5%	R$175.7b

Price-To-Earnings vs Peers: DHER34 is expensive based on its Price-To-Earnings Ratio (44x) compared to the peer average (39.7x).

Price to Earnings Ratio vs Industry

How does DHER34's PE Ratio compare vs other companies in the Global Life Sciences Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	0%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	0%
	n/a	n/a	n/a

No more companies

Price-To-Earnings vs Industry: DHER34 is expensive based on its Price-To-Earnings Ratio (44x) compared to the Global Life Sciences industry average (36.7x).

Price to Earnings Ratio vs Fair Ratio

What is DHER34's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DHER34 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	44x
Fair PE Ratio	22.8x

Price-To-Earnings vs Fair Ratio: DHER34 is expensive based on its Price-To-Earnings Ratio (44x) compared to the estimated Fair Price-To-Earnings Ratio (22.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.